26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
On February 10, 2020, the Attorney General issued revisions to the proposed regulations to the Calif...
Read More >
New Tripartite Advisory on Provision of Rest Areas for Outsourced Workers - New Regulation or Offic...
Read More >
The California Environmental Quality Act (CEQA) requires state and local government agencies to iden...
Read More >
As not just a new year but a new decade begins, we know from the closing days of 2019 that the Natio...
Read More >
It’s official: The Colorado Department of Labor and Employment’s Division of Labor Standards and S...
Read More >
Amending standard forms of construction and engineering contracts to change the risk level between t...
Read More >